Twin Research and Human Genetics Volume 10 Number 3 pp. 486-495 N eurofibromatosis type 1 (NF1) is the most frequent neurocutaneous disorder with autosomal dominant inheritance. Phenotype variability is high ranging from merely several café-au-lait spots to malignant peripheral nerve sheath tumors or severe disfigurement through plexiform neurofibromas. Identification of genetic factors that modify the NF1 phenotype would contribute to the understanding of NF1 pathophysiology and improve patient counselling. As even monozygotic (MZ) twins with NF1 may differ phenotypically, we wondered whether these variations might be inherited in a non-Mendelian fashion. Mitochondrial DNA (mtDNA) is inherited extrachromosomally through the cytoplasm of the oocyte and often harbours heteroplasmic sequence variations. At the time of blastomere separation, these variants may be skewedly distributed and effect phenotypic differences. Because of their co-localization with the tumor suppressor protein neurofibromin, which is mutated in NF1, mitochondria were particular attractive candidates for investigation. MtDNA was extracted from nucleated blood cells of four pairs of discordant MZ twins with NF1 and from cutaneous neurofibromas of one twin pair. We sequenced the entire mitochondrial genome and determined the state of heteroplasmy by investigating a microsatellite region of the mitochondrial D-loop (D310-tract). The clinical diagnosis was confirmed in all patients by detection of pathogenic mutations in the NF1 gene. Monozygosity was verified by genotyping. However, we did not detect evidence for mtDNA sequence differences or for different degrees of heteroplasmy between individuals of the same twin pair. The phenotypic discordance of MZ twins with NF1 cannot be explained by skewed distribution of mtDNA mutations or polymorphisms.
Neurofibromatosis type 1 (NF1) is a frequent neurocutaneous disorder with autosomal dominant inheritance. It affects worldwide approximately 1 in 3500 individuals and is caused by mutations in the NF1 gene. NF1 encodes the tumor suppressor protein neurofibromin Viskochil et al., 1990) .
Clinically, NF1 is characterized by cutaneous neurofibromas and pigment anomalies such as café-au-lait spots and skinfold freckling. Further defining criteria include the presence of iris hamartomas (Lisch nodules), optic pathway gliomas, plexiform neurofibromas and bone dysplasias (NIH, 1988; Theos & Korf, 2006) . The incidence of malignant tumors such as malignant peripheral nerve sheath tumors (MPNST) is increased. It is well known that NF1 disease severity may differ between patients to a large extent, even within a family. Some clinical reports document considerable phenotypic differences in monozygotic (MZ) twins. These comprise the age of disease onset and the severity of clinical signs and symptoms (Bauer et al., 1988; Easton et al., 1993) .
The nuclear genome of MZ twins is thought to be identical -at least in terms of DNA markers -as the separation of the blastomeres occurs early between day 1 and 10 after conception (Machin, 1996) . Therefore, the true nature of the phenotypic discordance in MZ twins remains poorly understood and speculations involve epigenetic mechanisms, genomic imprinting or the presence of chromosomal mosaics (Singh et al., 2002) .
Recent studies have shown that polymorphisms in the mitochondrial DNA (mtDNA) may influence the phenotype of inbred animals with identical nuclear genetic background (Johnson et al., 2001; Nagao et al., 1998; Roubertoux et al., 2003 has been shown that neurofibromin, the protein affected by mutations in the NF1-gene, partially colocalizes with mitochondria thus suggesting a functional link (Roudebush et al., 1997) . The mtDNA is therefore an obvious candidate for an extrachromosomal phenotype modifier.
The mtDNA is almost exclusively inherited through the maternal line. Every healthy women harbours a small percentage mutated mtDNA among the more than 100,000 copies that are present in the oocyte (Chen et al., 1995) . These mutations might be skewedly distributed between the blastomeres through the 'mitochondrial bottleneck' and subsequently expand into different degrees of heteroplasmy in the fetuses (Kirches et al., 2001) . Heteroplasmy is defined as the presence of two or more mtDNA populations in the same individual and different degrees of heteroplasmy have been shown to cause discordant symptoms in MZ twins with mitochondrial disorders (chronic progressive external ophthalmoplegia and Leber's hereditary optic neuropathy; Biousse et al., 1997; Blakely et al., 2004) .
In search for the molecular basis of phenotypic differences in NF1 we screened the entire mitochondrial genome for unevenly distributed mtDNA sequence variants in four twin pairs with 'identical' nuclear genetic background.
Patients
Four pairs of MZ twins of European descent (A-D) with neurofibromatosis type 1 were enrolled into the study. All individuals provided written informed consent for all aspects of this study and the publication of the results according to the Declaration of Helsinki. All patients fulfilled the NIH diagnostic criteria (NIH, 1988) . Monozygosity was verified by multi-locus DNA fingerprinting using synthetic simple repetitive oligonucleotides as probes (data not shown). In all individuals we detected NF1 mutations (3 frameshift mutations and 1 nonsense mutation). All patients received a detailed physical examination of the entire skin, and a cranial MRI. The twins of each pair differed in their phenotype, mainly in height and weight, head circumference, number and localization of neurofibromas and café-au-lait spots, as well as in additional disease specific features such as optic glioma and plexiform neurofibromas and further clinical signs as scoliosis and hydrocephalus (Table 1) .
Methods

Sample Collection and DNA Extraction
Blood samples of all individuals were collected by venipuncture. Additionally, we received specimens of neurofibromas from twins A1 and A2 that had been removed for cosmetic reasons by laser surgery, as well as blood from their mother. MtDNA was extracted from nucleated blood cells and from the cutaneous neurofibromas by standard procedures.
DNA Amplification and Sequencing
We screened the patients' DNA for sequence alterations in all exons of the NF1 gene by temperature gradient gel electrophoresis of polymerase chain reaction (PCR) amplified genomic DNA fragments using intron-based primers as previously described (Klose et al., 1998) . Silver staining was used for visualization of deviating bands. Prior to bidirectional automatic sequencing, PCR products were isolated and extracted from agarose gels. In order to preclude the analysis of mtDNA pseudogenes (Woischnik & Moraes, 2002) , we first amplified the major portion of the 16.5 kbp mtDNA molecule by long range PCR using the LA PCR Kit v2.1 (TaKaRa), with mtDNA specific oligonucleotid primers (f) 5'-TGA GGC CAA ATA TCA TTC TGA GGG GC-3' and (r) 5'-TTT CAT CAT GCG GAG ATG TTG GAT GG-3'. The long-range PCR product was then used as template for 17 nested PCR reactions with fragment lengths varying between 800 and 1200 bp. The complete list of primers used for the nested PCR reaction and for automatic cycle sequencing is available as supplementray material. A fragment of 250 bp within the cytochrome b (MT-CYB) gene that bridged the gap between the long-range PCR oligonucleotid primers was amplified by conventional PCR from native patient mtDNA samples. Therefore, coamplification of interfering nuclear pseudogenes in this region cannot be entirely excluded. For cycle sequencing on the ABI Prism 3700 DNA Sequencer (Applied Biosystems) we used the BigDye Terminator ® v2.0 protocol (Applied Biosystems) and nested primers (see supplementary material). Overlapping sequences were aligned to the revised Cambridge Reference Sequence (rCRS) and analysed with the software 'Sequence Navigator v1.0.1' (Applied Biosystems). Analysis of polymorphic sites and patient assignment into mtDNA haplogroups were performed with data from the Human Mitochondrial Genome Database (mtDB; Ingman & Gyllensten, 2005) .
Verification of the MZ state of the twins was done through multi-locus DNA fingerprinting. We used the synthetic oligonucleotide probe (GTG) 5 for the simultaneous detection of about 20 minisatellite loci (Neitzel et al., 1991) . Prior to agarose electrophoresis, genomic DNA was digested with the restriction endonucleases Mbo I and Hinf I. Identical patterns of up to 50 DNA fingerprint bands were observed in cases of MZ twins as apposed to a drastically reduced band sharing rate of only 50 to 60% in cases of dizygotic twins (data not shown).
Genotyping of the D310 Tract of the mtDNA
The D-loop of the mtDNA contains two hypervariable regions (HRVs) between nt16024-16383 (HVR1) and nt57-372 (HVR2). The mtDNA 5' to the thymine at nt310 contains a poly-cytosine tract which is called 'D310 tract'. The D310 tract generally occurs in heteroplasmic form, with several length variants, and can be used for genotyping (e.g., for forensic purposes). In our patients we used the genotyping method described earlier (Kirches et al., 2001) . Briefly, PCR was performed with a FAMlabelled forward-primer (FAM-GCC ACT TTC CAC ACA GAC ATC ATA-3', (r) 5'-TTA AAA GTG CAT ACC GCC AAA AG-3'). The ensuing products were digested with Hae III and the fluorescent fragment sizes were determined with the ABI Prism ® 3100 Genetic Analyzer (Applied Biosystems). With the 'Genescan Analysis Software v3.1' (Applied Biosystems), signals were transformed into curve diagrams, and the integral below the curve was taken as the relative amount of the respective length fragment. For generation of a length standard for genotyping, we cloned a mtDNA fragment containing the D310 tract of a healthy individual into the pGEM-T ® vector (Promega), and determined the length of the poly cytosine tract by automatic sequencing. The D310 tract length was analysed in mtDNA preparations from blood cells of all individuals and from the cutaneous neurofibromas of twin pair A.
Results
Sequence Analysis of the mtDNA
In the four twin pairs we found a total of 73 mtDNA sequence variants that deviated from the revised Cambridge Reference Sequence (rCRS). With the exception of 15947G in MT-TT (twin pair A), all variants were listed in the Human Mitochondrial Genome Database (mtDB). The variants placed the patients 
MT-TR, MT-TL2, MT-TT).
We did not detect any sequence variants in MTATP8 or in the remaining 19 tRNA genes. Twelve sequence variants were rare and occur worldwide in less than 1% of the normal population (Table 2 ). All variants were homoplasmic and we did not detect any difference in the presence of these variants between the individuals of the same twin pair. Additionally, we did not find any sequence differences between mtDNA preparations from blood and cutaneous neurofibromas in twin pair A.
Genotyping of the D310 Tract of the mtDNA
As the D-loop is difficult to sequence due to sequence heteroplasmy, we analysed the D310 tract by fragment length analysis. In the rCRS, the tract between nt303-316 has a length of 14 bp and length variations only occur in the poly-cyosine tract 5' to D310 (Parella et al., 2003) . Therefore, length analysis of the fragment spanning the D310 region accurately reflects the polymorphisms in the 5' polycytosine tract. All patients were heteroplasmic with 3 length variants of the D310 tract (Figure 2 ). The twin pairs B and C had a predominant length variant of 14 bp. In pair D there was heteroplasmy with 14-16 bp length variants. Twins A1 and A2 as well as their mother had three length variants of 15-17 bp in their mtDNA from blood cells. The distribution of the length variants was nearly the same in the children and their mother, with a tract length of 16 bp dominating with about 64% (Figure  2 ). We did not detect any significant differences in the degree of heteroplasmy between mtDNA preparations from blood and 16 cutaneous neurofibromas in twin pair A (Figure 2 ).
Discussion
In neurofibromatosis type 1 (NF1) the concordance of phenotypic features, such as the number of neurofibromas and café-au-lait spots, is high between MZ twins, and declines with lower degrees of relationship (Easton et al., 1993) . According to our hypothesis, polymorphisms or mutations of the mtDNA, which are inherited extrachromosomally through the maternal line, could make a difference between the genetic make-up of MZ twins and thus modify their phenotype. In order to exclude confounding factors of the nuclear genetic background, we investigated the mtDNA of discordant MZ twins. However, we did not detect any mtDNA differences between patients of the same twin pair, which renders mtDNA polymorphisms an unlikely cause for predisposition of phenotype variation, at least in our cohort of NF1 patients. Kösel et al. chose a similar approach and examined the mtDNA-encoded genes of complex I and the tRNAs in five pairs of identical twins with Parkinson's disease (Kösel et al., 2000) . Four of their twins were discordant for the disease at the time of analysis but no mtDNA sequence differences were found. Wilichowski et al. analysed the mtDNA of a pair of MZ twins one of whom was affected with X-linked adrenoleukodystrophy and did not detect any differences either (Wilichowski et al., 1998) . Most polymorphisms that we found were already noted in the mtDB database as sequence variants. The accumulation of sequence variants within the D-loop and the MT-CYB gene is not unexpected since these regions exhibit the highest genetic variability in population studies (Vega et al., 2004) . In contrast to most pathogenic mtDNA mutations that occur in heteroplasmic form (Kirches et al., 2001) , all sequence variants detected by us were homoplasmic and therefore probably without influence on the NF1 phenotype.
To search for late embryonic, somatic mtDNA mutations that might only be present in tissues of ectodermal origin, we also sequenced the entire mtDNA from cutaneous neurofibromas of twin pair A -the only one of whom the material was availablebut did not find any differences either. As mutations with a low degree of heteroplasmy (< 10-15%) might have gone unnoticed by the BigDye ® sequencing technology, we additionally used the genotyping technique of the D310-tract to detect quantitative differences between mtDNA extracted from the cutaneous neurofibromas and from nucleated blood cells. A quantitative shift could have served as additional, albeit indirect evidence, whether somatic segregation of heteroplasmic mtDNA mutations might have taken place, but we detected none.
In the absence of mtDNA alterations the discordance in our patients must be generated through other mechanisms. One might be the modification of genes or their expression patterns through epigenetic influences. It is known, that methylation may inactivate mismatch repair genes (Fraga et al., 2005; Jones & Laird, 1999) and the interaction of transcription factors with their binding sites can be altered by methylation (Mancini et al., 1999) which may lead to decreased NF1 gene expression. Other reasons might be the accumulation of random somatic (second hit) mutations in the NF1 gene (Serra et al., 2000) .
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